Swiss National Bank Sells 30,500 Shares of Docusign Inc. $DOCU

Swiss National Bank lessened its holdings in Docusign Inc. (NASDAQ:DOCU) by 5.0% during the third quarter, Holdings Channel.com reports. The firm owned 582,400 shares of the company’s stock after selling 30,500 shares during the quarter. Swiss National Bank’s holdings in Docusign were worth $41,985,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in DOCU. Twin Peaks Wealth Advisors LLC purchased a new position in Docusign during the second quarter valued at $43,000. SJS Investment Consulting Inc. raised its position in shares of Docusign by 5,318.2% in the 3rd quarter. SJS Investment Consulting Inc. now owns 596 shares of the company’s stock worth $43,000 after purchasing an additional 585 shares during the last quarter. CX Institutional raised its position in shares of Docusign by 5,860.0% in the 3rd quarter. CX Institutional now owns 596 shares of the company’s stock worth $43,000 after purchasing an additional 586 shares during the last quarter. Bessemer Group Inc. boosted its stake in Docusign by 66.9% in the 3rd quarter. Bessemer Group Inc. now owns 873 shares of the company’s stock worth $62,000 after purchasing an additional 350 shares in the last quarter. Finally, Abich Financial Wealth Management LLC purchased a new stake in Docusign during the 3rd quarter valued at about $67,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on DOCU shares. JPMorgan Chase & Co. cut their price target on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Wedbush lowered their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. BTIG Research decreased their price target on Docusign from $88.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. HSBC set a $53.00 price target on Docusign in a research note on Friday, February 13th. Finally, Piper Sandler cut their target price on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $78.80.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 6,500 shares of the business’s stock in a transaction that occurred on Friday, January 9th. The stock was sold at an average price of $70.00, for a total value of $455,000.00. Following the completion of the sale, the chief financial officer directly owned 111,713 shares in the company, valued at $7,819,910. The trade was a 5.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the transaction, the executive directly owned 68,970 shares in the company, valued at $4,624,438.50. This represents a 8.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 76,493 shares of company stock valued at $5,235,225. 1.01% of the stock is owned by insiders.

Docusign Stock Performance

NASDAQ DOCU opened at $46.48 on Friday. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $94.67. The firm’s 50 day moving average price is $52.17 and its 200-day moving average price is $65.18. The company has a market cap of $9.31 billion, a PE ratio of 32.50, a P/E/G ratio of 2.09 and a beta of 1.03.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: DocuSign named Brian Roberts to its board and struck a partnership with Anthropic to add AI-powered eSignature and contract-management features, which investors view as a catalyst for revenue expansion and product differentiation. DocuSign Board Refresh And Anthropic AI Deal Reframe Growth Story
• Positive Sentiment: Analyst and commentary pieces highlight steady subscription growth and renewed investor interest in DocuSign’s AI initiatives, which helped shares rally earlier in the month and support the case for medium-term upside. Reasons Why You Should Hold Docusign Stock in Your Portfolio
• Neutral Sentiment: DocuSign will report Q4 FY2026 results on March 17 — investors are focused on subscription growth, margin trends and any forward guidance changes that could drive short-term volatility. Dear DocuSign Stock Fans, Mark Your Calendars for March 17
• Neutral Sentiment: Wall Street estimates and modeled key metrics for Q4 are being closely watched (subscription net retention, billings, and operating leverage); results that beat or miss consensus could swing sentiment sharply. Curious about DocuSign (DOCU) Q4 Performance? Explore Wall Street Estimates for Key Metrics
• Negative Sentiment: Shares have fallen about 40% over the past year, raising valuation concerns and prompting debate whether the market has become overly pessimistic about growth prospects — that backdrop makes any earnings miss more punitive. Is DocuSign (DOCU) Now Attractive After A 40% One Year Share Price Decline
• Negative Sentiment: Near-term weakness is also reflected in recent daily declines versus the market and a consensus broker recommendation of “Hold,” which can limit upside until clearer evidence of durable growth or margin improvement appears. DocuSign (DOCU) Declines More Than Market: Some Information for Investors Docusign Inc. (NASDAQ:DOCU) Given Consensus Recommendation of “Hold” by Brokerages

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.